Search results for "Alcoholic"

showing 10 items of 509 documents

Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Non…

2019

Recent lines of evidence highlight the involvement of myeloid-epithelial-reproductive tyrosine kinase (MerTK) in metabolic disease associated with liver damage. MerTK is mainly expressed in anti-inflammatory M2 macrophages where it mediates transcriptional changes including suppression of proinflammatory cytokines and enhancement of inflammatory repressors. MerTK is regulated by metabolic pathways through nuclear sensors including LXRs, PPARs, and RXRs, in response to apoptotic bodies or to other sources of cholesterol. Nonalcoholic fatty liver disease (NAFLD) is one of the most serious public health problems worldwide. It is a clinicopathological syndrome closely related to obesity, insuli…

Drug targeting0301 basic medicineMacrophageMacrophage polarizationInflammationReviewMonocyteProinflammatory cytokine03 medical and health sciencesMerTK0302 clinical medicineFibrosisNonalcoholic fatty liver diseasemedicineNonalcoholic fatty liver diseaseMacrophagePharmacology (medical)InflammationPharmacologybusiness.industrylcsh:RM1-950Lipid metabolismMERTKmedicine.diseasemacrophagesAtherosclerosis; Drug targeting; Inflammation; Macrophages; MerTK; Monocytes; Nonalcoholic fatty liver diseaselcsh:Therapeutics. Pharmacology030104 developmental biologyAtherosclerosi030220 oncology & carcinogenesisCancer researchatherosclerosismedicine.symptommonocytesbusinessFrontiers in Pharmacology
researchProduct

Drug Induced Liver Injury (Dili) and Non Alcoholic Fatty Liver Disease (Nafld)

2020

This review article includes a review of the latest literature searched on PubMed in the field of hepatotoxicity caused by drugs that have a wide daily application. The concept of the review article consists of several parts dealing with the definition of drugs induced liver injury - DILI, diagnostic challenges related to it, and the clinical spectrum of liver disease, with an emphasis on the development of nonalcoholic fatty liver disease - NAFLD and review of drugs involved in formation of NAFLD.

DrugLiver injurymedicine.medical_specialtybusiness.industrymedia_common.quotation_subjectFatty liverNon alcoholicDiseasemedicine.diseaseGastroenterologyReview articleLiver diseaseInternal medicineNonalcoholic fatty liver diseasemedicinebusinessmedia_commonEuropean Journal of Medical and Health Sciences
researchProduct

Antioxidant Therapy and Drugs Interfering with Lipid Metabolism: Could They Be Effective in NAFLD Patients?

2013

This review is part of a special issue dealing with various aspects of non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). We will focus on promising treatments of NASH with antioxidants and drugs that interfere with lipid metabolism.The other therapies of interest, such as diet, behavioral changes, and insulin sensitizers are presented elsewhere. Oxidative stress is believed to play a key role in the pathogenesis of NASH and other liver diseases. Antioxidants aimed at improving chronic alcoholic or viral liver diseases have been an object of study for some time. However, only a few high quality, randomized, versus placebo-controlled, double-blinded trials hav…

DrugPathologymedicine.medical_specialtyCirrhosismedia_common.quotation_subjectDiseaseBioinformaticsAntioxidantsEzetimibeNon-alcoholic Fatty Liver DiseaseDiabetes mellitusHyperlipidemiaDrug DiscoverymedicineHumansmedia_commonPharmacologybusiness.industryFatty livernutritional and metabolic diseasesmedicine.diseaseLipid Metabolismdigestive system diseasesFatty LiverSteatosisAntioxidantbusinessmedicine.drugHumanCurrent Pharmaceutical Design
researchProduct

Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high-fat diet.

2015

Contains fulltext : 155347.pdf (Publisher’s version ) (Closed access) BACKGROUND/OBJECTIVES: In the context of obesity, epigenetic mechanisms regulate cell-specific chromatin plasticity, perpetuating gene expression responses to nutrient excess. MacroH2A1, a variant of histone H2A, emerged as a key chromatin regulator sensing small nutrients during cell proliferation and differentiation. Mice genetically ablated for macroH2A1 (knockout (KO)) do not show overt phenotypes under a standard diet. Our objective was to analyse the in vivo role of macroH2A1 in response to nutritional excess. METHODS: Twelve-week-old whole-body macroH2A1 KO male mice were given a high-fat diet (60% energy from lard…

EXPRESSIONCHROMATINNonalcoholic steatohepatitisModels Molecularmedicine.medical_specialtyHISTONE VARIANT MACROH2Amacrohistone H2A1 High fat diet obesity.Endocrinology Diabetes and MetabolismLIVER-DISEASE NAFLDTHERMOGENESISMedicine (miscellaneous)Adipose tissueBiologyDiet High-FatCell LineHistonesMiceINFLAMMATIONAdipose Tissue BrownThinnessInternal medicineBINDINGmedicineAnimalsGenetic ablationNutrition and DieteticsAdipogenesisNONALCOHOLIC STEATOHEPATITISTRANSCRIPTIONAL COREGULATOR PELP1medicine.diseaseNUTRITION&DIETETICSObesityDisease Models AnimalRenal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11]EndocrinologyEnergy expenditureFat dietOBESITYInsulin ResistanceEnergy MetabolismThermogenesisInternational journal of obesity (2005)
researchProduct

Non-Saccharomyces Yeasts nitrogen source preferences: Impact on sequential fermentation and wine volatile compounds profile

2017

International audience; Nitrogen sources in the must are important for yeast metabolism, growth, and performance, and wine volatile compounds profile. Yeast assimilable nitrogen (YAN) deficiencies in grape must are one of the main causes of stuck and sluggish fermentation. The nitrogen requirement of Saccharomyces cerevisiae metabolism has been described in detail. However, the YAN preferences of non-Saccharomyces yeasts remain unknown despite their increasingly widespread use in winemaking. Furthermore, the impact of nitrogen consumption by non-Saccharomyces yeasts on YAN availability, alcoholic performance and volatile compounds production by S. cerevisiae in sequential fermentation has b…

Effect of nitrogen on plantsaroma compoundsEfecte del nitrògen sobre les plantesSaccharomycetaceaeco-fermentation[ SDV.IDA ] Life Sciences [q-bio]/Food engineeringlcsh:QR1-502Winechardonnay winesnon-Saccharomyces yeastsyeast interactionslcsh:Microbiologysauvignon blancalcoholic fermentationnitrogen sources[SDV.IDA]Life Sciences [q-bio]/Food engineeringamino-acidViSacaromicetàciesvolatile compoundswineassimilable nitrogencerevisiaecatabolite repressiongrape juice
researchProduct

The economic cost and health burden of non-alcoholic steatohepatitis (NASH) in the EU5 countries

2020

Environmental healthEconomic costEconomicsmedicineNon alcoholicSteatohepatitismedicine.diseaseDGVS Digital: BEST OF DGVS
researchProduct

Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation.

2017

The importance of metabolic syndrome (MetS) lies in its associated risk of cardiovascular disease and type 2 diabetes, as well as other harmful conditions such as nonalcoholic fatty liver disease. In this report, the available scientific evidence on the associations between lifestyle changes and MetS and its components is reviewed to derive recommendations for MetS prevention and management. Weight loss through an energy-restricted diet together with increased energy expenditure through physical activity contribute to the prevention and treatment of MetS. A Mediterranean-type diet, with or without energy restriction, is an effective treatment component. This dietary pattern should be built …

Estils de vidamedicine.medical_specialtylifestyleSíndrome metabòlica -- PrevencióMedicine (miscellaneous)Dietary pattern030209 endocrinology & metabolismDiseaseType 2 diabetes030204 cardiovascular system & hematologypanel recommendationWhole grains03 medical and health scienceschemistry.chemical_compound0302 clinical medicineWeight lossEnvironmental healthCardiovascular DiseaseNonalcoholic fatty liver diseasemedicineHumansLife StyleMetabolic SyndromeNutrition and Dieteticsbusiness.industryFeature ArticleUnsaturated fatPanel recommendationDietary patternmedicine.diseaseLifestyleDietchemistryDiabetes Mellitus Type 2Cardiovascular DiseasesPhysical therapydietary patternMetabolic syndromemedicine.symptombusinessHuman
researchProduct

Influence of indigenous Hanseniaspora uvarum and Saccharomyces cerevisiae from sugar-rich substrates on the aromatic composition of loquat beer

2022

The demand for unique and exclusive food products and beverages is constantly on the increase. One of the products that mostly evolved to encounter market dynamics in the last decade is craft beer. For a long time, craft breweries have included fruit in beer production to enrich flavour and aroma profile of different beer styles. In this study, for the first time, the use of Saccharomyces and non-Saccharomyces yeast strains isolated from high -sugar matrices (manna and fermented honey by-products) were investigated to diversify fruit craft beer pro-duction, in order to improve the fermentation process and highlight the complexity of aroma profiles generated during alcoholic fermentation. Tw…

EthanolBeer aromaBeerWineHanseniaspora uvarumSaccharomyces cerevisiaeGeneral MedicineMicrobiologyHanseniasporaEriobotryaFermentationSettore AGR/16 - MICROBIOLOGIA AGRARIAVolatile organic compoundsAlcoholic fermentationSugarsLoquat beerFood ScienceInternational Journal of Food Microbiology
researchProduct

Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives

2019

General Immunology and MicrobiologyArticle Subjectbusiness.industryFatty liverlcsh:RMEDLINElcsh:MedicineGeneral Medicinemedicine.diseaseBioinformaticsAlcoholicGeneral Biochemistry Genetics and Molecular BiologyNOFatty LiverLiver diseaseText miningEditorialNon-alcoholic Fatty Liver DiseaseHumans; Fatty Liver Alcoholic; Non-alcoholic Fatty Liver DiseasemedicineDiagnostic assessmentHumansbusiness
researchProduct

Genetic background in nonalcoholic fatty liver disease: A comprehensive review

2015

In the Western world, nonalcoholic fatty liver disease (NAFLD) is considered as one of the most significant liver diseases of the twenty-first century. Its development is certainly driven by environmental factors, but it is also regulated by genetic background. The role of heritability has been widely demonstrated by several epidemiological, familial, and twin studies and case series, and likely reflects the wide inter-individual and inter-ethnic genetic variability in systemic metabolism and wound healing response processes. Consistent with this idea, genome-wide association studies have clearly identified Patatin-like phosholipase domain-containing 3 gene variant I148M as a major player i…

Genetic MarkersCandidate geneGenome-wide association studieHeredityPatatin-like phospholipase domain-containing 3Genome-wide association studyDiseaseReviewBiologymedicine.disease_causeGeneticNon-alcoholic Fatty Liver DiseaseRisk FactorsHeredityNonalcoholic fatty liver diseasemedicineHumansNonalcoholic fatty liver diseaseGenetic Predisposition to DiseaseGenetic variabilityGenetic associationGeneticsFatty liverGastroenterologyGenetic VariationGeneral Medicinemedicine.diseaseCandidate gene studiePedigreePhenotypeNonalcoholic steatohepatitiTransmembrane 6 superfamily member 2Candidate gene studies; Genetics; Genome-wide association studies; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Patatin-like phospholipase domain-containing 3; Transmembrane 6 superfamily member 2Genome-Wide Association Study
researchProduct